Alfuzosin + Dutasteride Tablets Manufacturer in India & Exporter | Contract Manufacturing

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Alfuzosin + Dutasteride Tablets are combination medications used in the management of benign prostatic hyperplasia (BPH), a condition characterized by enlargement of the prostate gland. The formulation combines Alfuzosin, an alpha-1 adrenergic blocker that relaxes smooth muscles in the prostate and bladder neck, with Dutasteride, a 5-alpha reductase inhibitor that reduces prostate enlargement. Genliva Wellness LLP is a trusted Alfuzosin + Dutasteride Tablet Manufacturer in India offering high-quality urology formulations for domestic and international pharmaceutical markets.

This combination therapy addresses both the symptoms and underlying progression of BPH. As a reliable Alfuzosin + Dutasteride Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Alfuzosin + Dutasteride Tablets are widely prescribed for improving urinary flow and reducing complications associated with enlarged prostate glands.

Alfuzosin + Dutasteride Tablets are formulated to provide dual-action management of benign prostatic hyperplasia.

Contains Alfuzosin and Dutasteride
Combines alpha-blocker and 5-alpha reductase inhibitor therapy
Relaxes prostate and bladder neck muscles
Helps reduce prostate gland enlargement
Dual-mechanism therapeutic approach
Oral tablet dosage form

Alfuzosin + Dutasteride Tablets are widely used in urology for:

Treatment of benign prostatic hyperplasia (BPH)
Improvement of urinary flow and reduction of urinary obstruction
Management of lower urinary tract symptoms (LUTS) such as:
- Frequent urination
- Weak urine stream
- Nocturia (night-time urination)
Reduction of prostate size over time
Prevention of acute urinary retention (AUR)
Lowering the need for surgical intervention in prostate enlargement

Alfuzosin + Dutasteride Tablets provide comprehensive management of BPH through complementary mechanisms.

Improves urinary flow
Addresses both symptoms and disease progression
Reduces prostate enlargement over time
Helps relieve urinary obstruction
Dual-action therapeutic benefit
Supports long-term prostate health management